Pages that link to "Q42460037"
Jump to navigation
Jump to search
The following pages link to A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome (Q42460037):
Displaying 50 items.
- Clinico-investigative Profile of Patients of Hirsutism in a Tertiary Level Institution (Q24611231) (← links)
- The management of infertility associated with polycystic ovary syndrome (Q24798425) (← links)
- Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers (Q26771828) (← links)
- Selection of the appropriate method for the assessment of insulin resistance (Q27001024) (← links)
- From Placenta to Polycystic Ovarian Syndrome: The Role of Adipokines (Q28073402) (← links)
- Longitudinal anti-müllerian hormone in women with polycystic ovary syndrome: an acupuncture randomized clinical trial (Q28388248) (← links)
- Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure (Q28535034) (← links)
- True and Sham Acupuncture Produced Similar Frequency of Ovulation and Improved LH to FSH Ratios in Women with Polycystic Ovary Syndrome (Q30424732) (← links)
- Assessment of Insulin Resistance and Impaired Glucose Tolerance in Lean Women with Polycystic Ovary Syndrome (Q30429162) (← links)
- Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome (Q31084944) (← links)
- Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications (Q33569169) (← links)
- Late pregnancy complications in polycystic ovarian syndrome (Q33598516) (← links)
- Metabolic abnormalities and cardiovascular risk factors in children with myositis (Q33602858) (← links)
- Diagnosis of polycystic ovary syndrome (Q33649429) (← links)
- Polycystic ovarian syndrome: diagnosis and management (Q33723471) (← links)
- Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. (Q33736175) (← links)
- Metabolomic Analysis Reveals Amino Acid Responses to an Oral Glucose Tolerance Test in Women with Prior History of Gestational Diabetes Mellitus (Q33738286) (← links)
- Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity (Q33886379) (← links)
- Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes (Q33903048) (← links)
- The comparison of insulin resistance frequency in patients with recurrent early pregnancy loss to normal individuals (Q34190360) (← links)
- Polycystic ovary syndrome. A diagnostic challenge (Q34212165) (← links)
- Polycystic ovary syndrome and ovulation induction (Q34212195) (← links)
- Effect of Metformin on Hormonal and Biochemical Profile in PCOS Before and After Therapy (Q34365181) (← links)
- Premature adrenarche (Q34444334) (← links)
- Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome (Q34512903) (← links)
- The association of the triglyceride-to-HDL cholesterol ratio with insulin resistance in White European and South Asian men and women (Q34515956) (← links)
- The ovarian androgen-producing cells: a 2001 perspective (Q34554533) (← links)
- The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome (Q34628402) (← links)
- Metal-on-metal hip prostheses and systemic health: a cross-sectional association study 8 years after implantation (Q34770577) (← links)
- Surrogate markers of insulin resistance: A review (Q34877758) (← links)
- Increase of long-term 'diabesity' risk, hyperphagia, and altered hypothalamic neuropeptide expression in neonatally overnourished 'small-for-gestational-age' (SGA) rats (Q35050357) (← links)
- Treatment of the adolescent patient with polycystic ovary syndrome (Q35167189) (← links)
- The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study (Q35181929) (← links)
- Androgen excess is the key element in polycystic ovary syndrome (Q35196443) (← links)
- The importance of insulin resistance in polycystic ovary syndrome (Q35196447) (← links)
- State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS) (Q35233754) (← links)
- Screening tests: a review with examples (Q35317799) (← links)
- Body morphology and its impact on adolescent and pediatric gynecology, with a special emphasis on polycystic ovary syndrome (Q35539105) (← links)
- A study of the prevalence of diabetes, insulin resistance, lipid abnormalities, and cardiovascular risk factors in patients with chronic plaque psoriasis (Q35564628) (← links)
- Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: a prospective, observational cohort study. (Q35566940) (← links)
- Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. (Q35599772) (← links)
- Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome? (Q35776475) (← links)
- PCOS: a diagnostic challenge (Q35787802) (← links)
- Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome (Q35787807) (← links)
- The clinical biochemistry of obesity. (Q35819237) (← links)
- E4orf1 Enhances Glucose Uptake Independent of Proximal Insulin Signaling (Q36107128) (← links)
- Associations of maternal weight status prior and during pregnancy with neonatal cardiometabolic markers at birth: the Healthy Start study (Q36132653) (← links)
- Determination of vitamin D in relation to body mass index and race in a defined population of black and white women (Q36223438) (← links)
- Correlation between serum lipid profile and carotid intima-media thickness in Polycystic Ovarian Syndrome (Q36263860) (← links)
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis (Q36298211) (← links)